Company intelligence / Profile preview

Enavate Sciences

Menlo Park, California, United Statesenavatesciences.com ↗

Ownership: Private
Development stage: Other

Overview

Enavate Sciences is an active life sciences investment firm focused on providing capital and strategic growth support to innovative therapeutic and enabling technology companies. It aims to accelerate the development of novel therapies addressing unmet medical needs across a broad range of indications by supporting both pre-clinical and clinical-stage ventures. The company was launched in 2022 with $300 million from Patient Square Capital.

Industry: Investors

Partnerships

Portfolio partnerships with innovative biotech/therapeutics firms such as Sionna Therapeuticsno major pharma co-development deals reported as of June 2025.

Beyond the preview

Go deeper on Enavate Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enavate Sciences.

Explore the full profile